The Saint Louis Institute (SLI) in the heart of Paris has initiated a large focused renewal process to become a leading centre for personalised medicine in onco/haematology. This includes building and refurbishing of new lab space of 4700 m2 that will take place under a four year time period. We will establish a research infrastructure that is based on strong clinical and pre-clinical research and supported by extensive platforms in protein chemistry, medicinal and in silico chemistry, imaging and translational research. We will strengthen existing research but also establish new teams. With respect to the latter, we will start to recruit new teams in 2011. In the first instance we are interested in a young team to establish his/her own research program using existing zebrafish facilities. We are interested in groups who will develop zebrafish model systems to study cell biological pathways implicated in the patophysiology of onco/haematological disorders. The French research organisations Inserm and CNRS have a 5 year program (Avenir/Atip) that is designed to get young scientists started in France. At the end of, or during this period the chances are good to secure a tenure research-only position within these organisations. Start-up packages from the SLI will also be made available.
For further information please contact:
Francois Sigaux, Institute director: fs9@wanadoo.fr
Hugues deThe, Scientific director: dethe@univ-paris-diderot.fr
Robin Fahraeus, Research director: robin.fahraeus@inserm.fr


